Application no. and date | 11192705.9 (espacenet) (Federated) (European Patent Register), 20070713 | Patent/reg. no. and date | DK/EP 2468770, 20171220 | Publication date | 20120627 | Priority no. and date | EP 06014730, 20060714, EP 06020765, 20061002, US 94328907 P, 20070611, US 94349907 P, 20070612 | EP pub. no. and date |
EP 2468770 20120627 | Effective date | | Applicant/owner | Genentech, Inc., One DNA Way South San Francisco, CA 94080-4990, US, AC Immune S.A., EPFL Innovation Park Building B
1015 Lausanne, CH | Applicant ref. no. | P63893DK01 | Inventor | WATTS, Ryan, 524 Yale Drive
San Mateo, CA 94402, US, PIHLGREN BOSCH, Maria, Chemin du Tessin 6B
1052 Mont-sur-Lausanne, CH, Pfeifer, Andrea, Route de Fenil 16A
1806 St.-Légier, CH, Muhs, Andreas, Chemin des Alouettes 12
1053 Cugny, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61P 25/28 (2006.01) , C07K 16/18 (2006.01) | Title | Humaniseret antistof mod amyloid beta | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|